机构：[1]Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China[2]Imaging and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, China[3]Department of Minimally Invasive Interventional Therapy, Shenzhen Hospital of Beijing University, Shenzhen, China北京大学深圳医院深圳市康宁医院深圳医学信息中心[4]Department of Oncology, Fuxing Hospital Affiliated to the Capital University of Medical Sciences, Beijing, China[5]Department of Interventional Therapy, Hunan Provincial Tumor Hospital, Changsha, China[6]Department of Imaging, Tumor Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China[7]Department of Thoracic Surgery, Shanxi Provincial Tumor Hospital, Xi’an, China[8]Department of Radiology, Peking Union Medical College Hospital, Beijing, China[9]Interventional Treatment Center, Shandong University Second Hospital, Jinan, China[10]Research Office of CT Diagnosis and Treatment, Shandong Provincial Institute of Medical Imaging, Jinan, China[11]Department of Interventional Therapy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China[12]Department of Thoracic Surgery, Xuanwu Hospital Affiliated to the Capital University of Medical Sciences, Beijing, China外科系统胸外科首都医科大学宣武医院[13]Department of Oncology, Armed Police Hospital of Guangdong Province, Guangzhou, China[14]Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China[15]Interventional Treatment Center, Jilin Provincial Tumor Hospital, Changchun, China[16]Department of Tumor Minimally Invasive Therapy, 307 Hospital, Beijing, China[17]Tumor Interventional Therapy Center, Shanghai Renji Hospital, Shanghai, China[18]Center of Lung Cancer, the First Affiliated Hospital of China Medical University, Shenyang, China
Although surgical resection is the primary means of curing both primary and metastatic lung cancers, about 80% of lung cancers cannot be removed by surgery. As most patients with unresectable lung cancer receive only limited benefits from traditional radiotherapy and chemotherapy, many new local treatment methods have emerged, including local ablation therapy. The Minimally Invasive and Comprehensive Treatment of Lung Cancer Branch, Professional Committee of Minimally Invasive Treatment of Cancer of the Chinese Anti-Cancer Association has organized multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim at standardizing thermal ablation procedures and criteria for selecting treatment candidates and assessing outcomes; and for preventing and managing post-ablation complications.
第一作者机构：[1]Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China[*2]Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250014, China
通讯作者：
通讯机构：[*1]Imaging and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.[*2]Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250014, China
推荐引用方式(GB/T 7714)：
Xin Ye,Weijun Fan,Jun-hui Chen,et al.Chinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors[J].THORACIC CANCER.2015,6(1):112-121.doi:10.1111/1759-7714.12152.
APA：
Xin Ye,Weijun Fan,Jun-hui Chen,Wei-jian Feng,Shan-zhi Gu...&Jun Zhang.(2015).Chinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors.THORACIC CANCER,6,(1)
MLA：
Xin Ye,et al."Chinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors".THORACIC CANCER 6..1(2015):112-121
